CIPROFLOXACIN AND NORFLOXACIN FOR SELECTIVE DECONTAMINATION IN PATIENTS WITH SEVERE GRANULOCYTOPENIA

被引:41
作者
MASCHMEYER, G
HARALAMBIE, E
GAUS, W
KERN, W
DEKKER, AW
DEVRIESHOSPERS, HG
SIZOO, W
KONIG, W
GUTZLER, F
DAENEN, S
机构
[1] UNIV ESSEN GESAMTHSCH,DEPT MICROBIOL,D-4300 ESSEN 1,FED REP GER
[2] UNIV ULM,DEPT DOCUMENTAT & STAT,D-7900 ULM,FED REP GER
[3] UNIV ULM,DEPT INTERNAL MED,D-7900 ULM,FED REP GER
[4] UNIV ULM,DEPT CLIN INFECTIOL,D-7900 ULM,FED REP GER
[5] UNIV HOSP UTRECT,DEPT HAEMATOL,3500 CG UTRECT,NETHERLANDS
[6] STATE UNIV GRONINGEN HOSP,MED MICROBIOL LAB,9713 EZ GRONINGEN,NETHERLANDS
[7] DR DANIEL DENHOED CANC CTR,DEPT HAEMATOL & ONCOL,3000 AA ROTTERDAM,NETHERLANDS
[8] RUHR UNIV BOCHUM,DEPT MED MICROBIOL & IMMUNOL,D-4630 BOCHUM 1,FED REP GER
[9] UNIV HOSP HEIDELBERG,DEPT CLIN PHARMACOL,D-6900 HEIDELBERG,FED REP GER
[10] STATE UNIV GRONINGEN HOSP,DEPT HAEMATOL & ONCOL,9713 EZ GRONINGEN,NETHERLANDS
关键词
D O I
10.1007/BF01644312
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:98 / 104
页数:7
相关论文
共 31 条
[1]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[2]   BACTERICIDAL KINETICS AND SELECTION OF RESISTANT MUTANTS BY 4-QUINOLONES AT CONCENTRATIONS FOLLOWING THEIR SERUM PHARMACOKINETICS [J].
BAUERNFEIND, A ;
PETERMULLER, C ;
HEINRICH, B ;
GABLAC, R .
INFECTION, 1986, 14 :S26-S30
[3]  
BODEY GP, 1978, CANCER, V41, P1610, DOI 10.1002/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO
[4]  
2-B
[5]   CHANGES IN THE PHARMACOKINETICS OF CIPROFLOXACIN AND FECAL FLORA DURING ADMINISTRATION OF A 7-DAY COURSE TO HUMAN VOLUNTEERS [J].
BRUMFITT, W ;
FRANKLIN, I ;
GRADY, D ;
HAMILTONMILLER, JMT ;
ILIFFE, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :757-761
[6]   CAUSES OF DEATH IN ADULTS WITH ACUTE-LEUKEMIA [J].
CHANG, HY ;
RODRIGUEZ, V ;
NARBONI, G ;
BODEY, GP ;
LUNA, MA ;
FREIREICH, EJ .
MEDICINE, 1976, 55 (03) :259-268
[7]   CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326
[8]   RECOVERY OF NORFLOXACIN IN FECES AFTER ADMINISTRATION OF A SINGLE ORAL DOSE TO HUMAN VOLUNTEERS [J].
COFSKY, RD ;
DUBOUCHET, L ;
LANDESMAN, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) :110-111
[9]   TISSUE DISTRIBUTION OF CIPROFLOXACIN FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION [J].
DALHOFF, A ;
EICKENBERG, HU .
INFECTION, 1985, 13 (02) :78-81
[10]   INFECTION PROPHYLAXIS IN ACUTE-LEUKEMIA - A COMPARISON OF CIPROFLOXACIN WITH TRIMETHOPRIM-SULFAMETHOXAZOLE AND COLISTIN [J].
DEKKER, AW ;
ROZENBERGARSKA, M ;
VERHOEF, J .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) :7-12